TFPI2 and cancer: This is consistent with data available from the ENCODE project that also shows differences in the levels of the heterochromatic mark H3K27me3 between normal cells (HMEC), which are devoid of this mark and MCF-7 cancer cells that display H3K27me3 enrichment at TFPI-2 (Supplementary Figure S7).